CK Life Sciences Int'l. (Holdings) Inc. (00775) submitted a monthly return for the period ended 30 November 2025, indicating no changes in its authorized share capital or issued shares. The authorized share capital remained at 15,000,000,000 ordinary shares with a par value of HKD 0.1 each, totaling HKD 1,500,000,000.

As of 30 November 2025, the issuer reported 9,611,072,400 issued ordinary shares and no treasury shares, reflecting no movements from the preceding month. No details were provided regarding share options, warrants, convertibles, or other agreements that could affect share issuance. The submission was filed on 02 December 2025 by the company secretary, confirming the figures stated above.